Hepatitis C virus genotype 5 variability in treatment naïve patients in South Africa
Introduction. Hepatitis C virus (HCV) genotype 5 was originally identified in South Africa, where it represents 35-60% of all HCV infections. There are limited data on resistance associated variants (RAVs) in South Africa. Thus, we investigated variability within the NS3/NS4A, NS5A, and NS5B gene...
Main Authors: | Tshegofatso K. Maunye, Maemu P. Gededzha, Jason T. Blackard, Johnny N. Rakgole, Selokela G. Selabe |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2023-05-01
|
Series: | Intervirology |
Online Access: | https://beta.karger.com/Article/FullText/528178 |
Similar Items
-
Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans
by: Azwidowi Lukhwareni, et al.
Published: (2020-06-01) -
A novel hepatitis B virus recombinant genotype D4/E identified in a South African population
by: Mmatsatsi K. Matlou, et al.
Published: (2019-04-01) -
Prediction of immunological T-cell epitopes of hepatitis C virus genotype 5a
by: M.P. Gededzha, et al.
Published: (2014-04-01) -
Evidence for shifting hepatitis B virus population epidemiology after nearly two decades of universal hepatitis B vaccination in South Africa
by: E. Amponsah-Dacosta, et al.
Published: (2014-04-01) -
High prevalence of and factors associated with human papillomavirus infection among women attending a tertiary hospital in Gauteng Province, South Africa
by: Teboho Amelia Tiiti, et al.
Published: (2022-08-01)